Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy

por Glaspy, J A, Jadeja, J S, Justice, G, Kessler, J, Richards, D, Schwartzberg, L, Tchekmedyian, N S, Armstrong, S, O'Byrne, J, Rossi, G, Colowick, A B
Publicado 2002

A dose- and schedule-finding study of darbepoetin alpha for the treatment of chronic anaemia of cancer

por Smith, R E, Tchekmedyian, N S, Chan, D, Meza, L A, Northfelt, D W, Patel, R, Austin, M, Colowick, A B, Rossi, G, Glaspy, J
Publicado 2003

Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer

por Smith, R E, Jaiyesimi, I A, Meza, L A, Tchekmedyian, N S, Chan, D, Griffith, H, Brosman, S, Bukowski, R, Murdoch, M, Rarick, M, Saven, A, Colowick, A B, Fleishman, A, Gayko, U, Glaspy, J
Publicado 2001

A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy

por Glaspy, J, Jadeja, J Singh, Justice, G, Kessler, J, Richards, D, Schwartzberg, L, Rigas, J, Kuter, D, Harmon, D, Prow, D, Demetri, G, Gordon, D, Arseneau, J, Saven, A, Hynes, H, Boccia, R, O'Byrne, J, Colowick, A B
Publicado 2001